Results for "Understanding Pharmaceutical Distribution"
HDA Statement on FDA Enforcement Discretion for the DSCSA’s Final Implementation Requirements
The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) announcement that it plans to exercise enforcement discretion for the Drug Supply Chain Security Act’s (DSCSA) final implementation requirements.
HDA’s Chip Davis Assesses State of the Distribution Industry at 2021 BLC Online
HDA President and CEO Chip Davis recently spoke at the 2021 BLC Online about the unique role of the healthcare distribution industry in combating COVID-19, how distributors continue to rise to its challenges and what is still needed to turn the corner on the pandemic, among other association priorities.
Ariella Camera Joins HDA as Senior Director of Policy
The Healthcare Distribution Alliance (HDA) announces the addition of Ariella Camera as Senior Director of Policy. In this role, Ms. Camera will inform policy development on key issues impacting the healthcare distribution industry and report to HDA’s Chief Policy Officer, Dr. Nicolette Louissaint.
Member Spotlight: When Distribution Is a Family Calling
While the business of pharmaceutical distribution has changed significantly over the past eight decades, HDA members like Capital Wholesale Drug Company (Capital Drug) have continued to play an essential role in providing safe and efficient healthcare delivery to trusted pharmacists and providers.